Seth L. Harrison
About Seth L. Harrison
Seth L. Harrison - Founder and Managing Partner
Seth L. Harrison is the Founder and Managing Partner at ATP. With a long-standing presence in the venture capital sector, he has significantly contributed to life sciences investments since 1991. His career began at Sevin Rosen Funds, where he functioned as a venture partner. Before establishing ATP, Seth Harrison was a general partner at Oak Investment Partners. His early investments include companies such as Aileron Therapeutics, Akero Therapeutics, ArQule, and ViroPharma.
Seth L. Harrison Education Background
Seth L. Harrison holds an AB from Princeton University and an MD and MBA from Columbia University. His educational background is complemented by practical medical experience, having completed a surgery internship at the Presbyterian Hospital in the City of New York. This diverse educational portfolio has equipped him with a robust foundation to drive impactful investments in the life sciences sector.
Seth L. Harrison - Investment Experience
Seth L. Harrison has been an active investor in the life sciences sector since 1991, beginning his investment career as a venture partner at Sevin Rosen Funds. Afterward, he served as a general partner at Oak Investment Partners. Throughout his career, he has made early investments in several notable companies including Aileron Therapeutics, Akero Therapeutics, ArQule, and ViroPharma, demonstrating his adeptness in identifying and nurturing pioneering biopharmaceuticals and healthcare innovations.
Seth L. Harrison - Board Memberships
Currently, Seth L. Harrison serves on the boards of Akero Therapeutics and Stoke Therapeutics, contributing his extensive expertise and experience in the life sciences and venture capital sectors. Notably, he also served on the board of the International Partnership for Microbicides from 2002 to 2010, showcasing his commitment to advancing global health initiatives and tackling challenging healthcare issues.